Natural Products as a Foundation for Drug Discovery

Many natural products have been used as drugs for the treatment of diverse indications. Although most U.S. pharmaceutical companies have reduced or eliminated their in‐house natural‐product research over the years, new approaches for compound screening and chemical synthesis are resurrecting interest in exploring the therapeutic value of natural products. The aim of this commentary is to review emerging strategies and techniques that have made natural products a viable strategic choice for inclusion in drug discovery programs. Published 2019. U.S. Government.

• Publication year

  2019

• Venue

  Current Protocols in Pharmacology

• Publication date

  2019-08-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cpph.67PMID 20161632PMCID PMC7442317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eribulin mesylate

  2021cited by this paper
• Remodeling of the Natural Product Fumagillol Employing a Reaction Discovery Approach

  2011cited by this paper
• Marine chemical ecology in benthic environments.

  2011cited by this paper
• Diversity-oriented synthesis leads to an effective class of bifunctional linchpins uniting anion relay chemistry (ARC) with benzyne reactivity

  2011cited by this paper
• A brief synthesis of (-)-englerin A.

  2011cited by this paper
• Case History: Discovery of Eribulin (HALAVEN™), a Halichondrin B Analogue That Prolongs Overall Survival in Patients with Metastatic Breast Cancer

  2011cited by this paper
• Development of a High-Throughput Cell-Based Reporter Assay to Identify Stabilizers of Tumor Suppressor Pdcd4

  2010cited by this paper
• Enantioselective synthesis of (-)-englerins A and B.

  2010cited by this paper
• High Throughput Extraction of Plant, Marine and Fungal Specimens for Preservation of Biologically Active Molecules

  2010cited by this paper
• Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri.

  2009cited by this paper
• Total synthesis and absolute configuration of the guaiane sesquiterpene englerin A.

  2009cited by this paper
• A cell-based high-throughput screen to identify synergistic TRAIL sensitizers

  2009cited by this paper
• Ketosynthase III as a gateway to engineering the biosynthesis of antitumoral benastatin derivatives.

  2009cited by this paper
• Bacterial hosts for natural product production.

  2008cited by this paper
• Natural products as leads to potential drugs: an old process or the new hope for drug discovery?

  2008cited by this paper
• Biosynthetic origin of natural products isolated from marine microorganism–invertebrate assemblages

  2008cited by this paper
• “Missing” protists: a molecular prospective

  2008cited by this paper
• Marine chemical ecology.

  2008cited by this paper
• Bioactive Endophytes Warrant Intensified Exploration and Conservation

  2008cited by this paper
• Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy.

  2008cited by this paper
• Pre-fractionated Microbial Samples – The Second Generation Natural Products Library at Wyeth

  2008cited by this paper
• Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.

  2008cited by this paper
• Evolving trends in the dereplication of natural product extracts: new methodology for rapid, small-scale investigation of natural product extracts.

  2008cited by this paper
• Application of epothilones in breast cancer therapy

  2008cited by this paper
• Fractionated Marine Invertebrate Extract Libraries for Drug Discovery

  2008cited by this paper
• Natural product drug discovery: the times have never been better.

  2007cited by this paper
• Natural products as sources of new drugs over the last 25 years.

  2007cited by this paper
• FTICR-MS applications for the structure determination of natural products

  2007cited by this paper
• Journal of Translational Medicine BioMed Central Review

  2007cited by this paper
• Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.

  2007cited by this paper
• From the Zulu medicine to the European phytomedicine Umckaloabo.

  2007cited by this paper
• Oribatid mites as a major dietary source for alkaloids in poison frogs

  2007cited by this paper
• Eribulin, a simplified ketone analog of the tubulin inhibitor halichondrin B, for the potential treatment of cancer.

  2007cited by this paper
• A High-Throughput Cell-Based Assay to Identify Specific Inhibitors of Transcription Factor AP-1

  2007cited by this paper
• Synthesis of OSW saponin analogs with modified sugar residues and their antiproliferative activities.

  2007cited by this paper
• G protein-coupled time travel: evolutionary aspects of GPCR research.

  2007cited by this paper
• Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals.

  2006cited by this paper
• Comparison of the Activities of the Truncated Halichondrin B Analog NSC 707389 (E7389) with Those of the Parent Compound and a Proposed Binding Site on Tubulin

  2006cited by this paper
• Genomic analyses lead to novel secondary metabolites. Part 3. ECO-0501, a novel antibacterial of a new class.

  2006cited by this paper
• Genomic Analyses Lead to Novel Secondary Metabolites

  2006cited by this paper
• A High-Throughput Cell-Based Assay for Inhibitors of ABCG2 Activity

  2006cited by this paper
• Protecting traditional knowledge: the San and hoodia.

  2006cited by this paper
• Sequestration and possible role of dietary alkaloids in the sponge-feeding mollusk Tylodina perversa.

  2006cited by this paper
• RELATIONSHIPS BETWEEN PLANT FOLKLORE AND ANTITUMOR ACTIVITY: AN HISTORICAL REVIEW 1

  2005cited by this paper
• Exploiting new approaches for natural product drug discovery in the biotechnology industry.

  2005cited by this paper
• Rhetoric, Realism and Benefit‐Sharing

  2005cited by this paper
• Plants as a source of anti-cancer agents.

  2005cited by this paper
• International collaboration in drug discovery and development from natural sources

  2005cited by this paper
• Natural products to drugs: natural product-derived compounds in clinical trials.

  2005cited by this paper
• Role of the A-ring of bryostatin analogues in PKC binding: synthesis and initial biological evaluation of new A-ring-modified bryologs.

  2005cited by this paper
• In situ DMSO hydration measurements of HTS compound libraries.

  2005cited by this paper
• Alkaloids from amphibian skin: a tabulation of over eight-hundred compounds.

  2005cited by this paper
• Preparative chromatography techniques: Applications in natural product isolation

  2004cited by this paper
• bryA: an unusual modular polyketide synthase gene from the uncultivated bacterial symbiont of the marine bryozoan Bugula neritina.

  2004cited by this paper
• The antibiotic pipeline--challenges, costs, and values.

  2004cited by this paper
• Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549.

  2004cited by this paper
• Formicine ants: An arthropod source for the pumiliotoxin alkaloids of dendrobatid poison frogs.

  2004cited by this paper
• Marine natural products.

  2004cited by this paper
• A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells.

  2004cited by this paper
• Generating Diverse Skeletons of Small Molecules Combinatorially

  2003cited by this paper
• The structure of velutinoside A: a pregnane pentasaccharide from Mandevilla velutina

  2003cited by this paper
• Aquaculture of three phyla of marine invertebrates to yield bioactive metabolites: process developments and economics.

  2003cited by this paper
• A Siphonotid Millipede (Rhinotus) as the Source of Spiropyrrolizidine Oximes of Dendrobatid Frogs

  2003cited by this paper
• Choosing the best pulse sequences, acquisition parameters, postacquisition processing strategies, and probes for natural product structure elucidation by NMR spectroscopy.

  2002cited by this paper
• A double blind, randomized, placebo-controlled study of SP-303 (Provir) in the symptomatic treatment of acute diarrhea among travelers to Jamaica and Mexico

  2002cited by this paper
• Combinatorial synthesis of natural product-like molecules using a first-generation spiroketal scaffold.

  2002cited by this paper
• High-throughput method for the production and analysis of large natural product libraries for drug discovery.

  2002cited by this paper
• Milestones in camptothecin research

  2002cited by this paper
• A polyketide synthase-peptide synthetase gene cluster from an uncultured bacterial symbiont of Paederus beetles

  2002cited by this paper
• Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin.

  2001cited by this paper
• Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases.

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Pure compound libraries; a new perspective for natural product based drug discovery.

  2001cited by this paper
• Allelopathic prenylflavanones from the fallen leaves of Macaranga tanarius.

  2001cited by this paper
• Tannins: classification and definition.

  2001cited by this paper
• Exploring chemical diversity of epoxyquinoid natural products: synthesis and biological activity of (-)-jesterone and related molecules.

  2001cited by this paper
• Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado.

  2001cited by this paper
• Structure-activity relationships of halichondrin B analogues: modifications at C.30-C.38.

  2000cited by this paper
• Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure.

  2000cited by this paper
• Marine natural products.

  2000cited by this paper
• A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS

  1999cited by this paper
• The discovery and development of marine compounds with pharmaceutical potential.

  1999cited by this paper
• COSTA RICAN INTERNATIONAL COOPERATIVE BIODIVERSITY GROUP: USING INSECTS AND OTHER ARTHROPODS IN BIODIVERSITY PROSPECTING

  1999cited by this paper
• The Lobatamides, Novel Cytotoxic Macrolides from Southwestern Pacific Tunicates†

  1998cited by this paper
• Asymmetric Synthesis of Bryostatin 2.

  1998cited by this paper
• Pyranocoumarins from tropical species of the genus Calophyllum: a chemotaxonomic study of extracts in the National Cancer Institute collection.

  1998cited by this paper
• Combinatorial chemistry in insects: a library of defensive macrocyclic polyamines.

  1998cited by this paper
• Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.

  1997cited by this paper
• Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications

  1997cited by this paper
• An Information-Intensive Approach to the Molecular Pharmacology of Cancer

  1997cited by this paper
• Structural Elucidation of YM-75518, A Novel Antifungal Antibiotic Isolated from Pseudomonas sp. Q38009

  1997cited by this paper
• Complete Relative Stereochemistry of Maitotoxin

  1996cited by this paper
• Plant Alkaloids: A Guide to Their Discovery and Distribution

  1996cited by this paper
• Further Studies on Phorbol Ester Bioactivity in the Euphorbiaceae

  1996cited by this paper
• The Complete Structure of Maitotoxin, Part I: Configuration of the C1C14 Side Chain

  1996cited by this paper
• Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal.

  1996cited by this paper
• A reinvestigation of Maprounea triterpenes.

  1995cited by this paper
• Epibatidine, a potent analgetic and nicotinic agonist.

  1994cited by this paper
• Strategies for Database Dereplication of Natural Products

  1994cited by this paper
• Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303.

  1994cited by this paper

• Selective Cytotoxic and Antiproliferative Effects of Extracts from Four Mexican Medicinal Plants in Human Cancer and Non-Cancerous Cell Lines

  2026cites this paper
• Unveiling the Novel Multitarget Antidepressant Mechanisms of Ligustilide in Postpartum Depression: An Integrative Network Pharmacology and Molecular Simulation Study

  2026cites this paper
• Diketopiperazines with In vivo Antimalarial Activity from Sponge-derived Streptomyces sp. 13-12-16

  2026cites this paper
• Water-Mediated Synthesis of Oxindole-Embedded Chalcone Hybrids: Anticancer Evaluation and Computational Insights

  2026cites this paper
• Induced mutations, cell line selections, nanoparticles and cyclodextrins for improving secondary metabolite accumulation in vitro

  2026cites this paper
• Takeda G Protein-Coupled Receptor 5 and Peroxisome Proliferator-Activated Receptor-Gamma Activation by Pinocembrin and Pinostrobin Isolated from Lindera sericea.

  2026cites this paper
• Structure-Based Insights into TGR5 Activation by Natural Compounds: Therapeutic Implications and Emerging Strategies for Obesity Management

  2025cites this paper
• Type II polyketide synthases: Impact on human health, current knowledge, and future directions

  2025cites this paper
• A Scoping Review of Chemical, Pharmacological and Toxicological Properties and Clinical Applications of Australian Indigenous Medicine.

  2025cites this paper
• Propolis Improved Methomyl-Induced Neurotoxicity in the Developing Brain of Albino Rats.

  2025cites this paper
• Processing from natural products to effective pharmaceutical drugs: involvement of hot melt extrusion technique.

  2025cites this paper
• Pharmacoinformatics in identifying therapeutically important chemical species from Ayurvedic formulations employed in treating COVID-19 patients

  2025cites this paper
• Discovery of Ganodecalone A, from Ganoderma calidophilum for the treatment of acute gastric ulcers by binding to ALOX5 via the MAPK/NF-κB/iNOS signaling.

  2025cites this paper
• Integrative in silico and in vivo Drosophila model studies reveal the anti-inflammatory, antioxidant, and anticancer properties of red radish microgreen extract

  2025cites this paper
• Natural Mimetic 4,6-dihydroxyaurone Derivatives as Tyrosinase Inhibitors: Design, Synthesis, and Biological Evaluation.

  2025cites this paper
• Therapeutic potential of anti-cancer compounds from African medicinal plants: From in vitro studies to clinical applications

  2025cites this paper
• High-throughput protein crystallography to empower natural product-based drug discovery.

  2025cites this paper
• Comparative Effects of Turmeric Secondary Metabolites Across Resorptive Bone Diseases

  2025cites this paper
• Uvarinol and Dichamanetin Derived from Uvaria chamae as Potential Dual-Site Inhibitors Against PBP2a in Methicillin Resistant Staphylococcus aureus: An In Silico Study

  2025cites this paper
• Discovery of Novel Multiangiogenic Agents Targeting VEGFR2, EphB4, FGFR-1, and TIE-2: Receptor-Based Pharmacophore Modeling, Virtual Screening, and Molecular Modeling Studies

  2025cites this paper
• Exploring the potential of Cucumis melo phytoconstituents for treating diabetic neuropathy using in silico molecular docking and simulation: An experimental study

  2025cites this paper
• Fraksi Bioaktif dan Inovasi Terapeutik: Jembatan Etnofarmasi dan Sains Modern

  2025cites this paper
• Potentilla fulgens Wall ex Sims. exerts anti-diabetic effects by inhibiting α-amylase and α-glucosidase: deeper insights through molecular docking

  2025cites this paper
• Investigating the Epigenetic Therapeutic Potential of Natural Compounds in Cancer

  2025cites this paper
• Potentiation of the antimycobacterial activity of bedaquiline, clofazimine, and doxycycline against Mycobacterium smegmatis by several natural product-based compounds is putatively via efflux inhibition

  2025cites this paper
• Disruption of histidine biosynthesis in Acinetobacter baumannii by Tubuloside B from Cistanche tubulosa

  2025cites this paper
• Phytochemicals for High-Throughput Screening in Drug Discovery: Ever Thought of Sprouts?

  2025cites this paper
• Black soldier fly (Hermetia illucens L.): A potential small mighty giant in the field of cosmeceuticals

  2024cites this paper
• The Antibacterial Activity of Yeasts from Unique Biocenoses

  2024cites this paper
• Coriander: A holistic outlook on its chemistry and pharmacology.

  2024cites this paper
• Catalytic Enantioselective C-C Coupling of Alcohols for Polyketide Total Synthesis beyond Chiral Auxiliaries and Premetalated Reagents.

  2024cites this paper
• Progress in the discovery and development of anticancer agents from marine cyanobacteria

  2024cites this paper
• Pioneering plant metabolomic library of Indonesian plants for research, conservation, capacity building and economic development

  2024cites this paper
• Beyond traditional screening: Unveiling antibiotic potentials of actinomycetes in extreme environments

  2024cites this paper
• Exploring Xenorhabdus and Photorhabdus Nematode Symbionts in Search of Novel Therapeutics

  2024cites this paper
• An In Silico Approach to Discover Efficient Natural Inhibitors to Tie Up Epstein–Barr Virus Infection

  2024cites this paper
• Target Fisher: a Consensus Structure-Based Target Prediction Tool, and its Application in the Discovery of Selective MAO-B Inhibitors.

  2024cites this paper
• Family Malvaceae: a potential source of secondary metabolites with chemopreventive and anticancer activities supported with in silico pharmacokinetic and pharmacodynamic profiles

  2024cites this paper
• Phytochemicals of Swertia chirayita Roxb. ex Fleming against malarial dihydroorotate dehydrogenase: an in silico study

  2024cites this paper
• Poly(ADP-Ribose) Polymerase (PARP) Inhibitors for Cancer Therapy: Advances, Challenges, and Future Directions

  2024cites this paper
• Molecularly Imprinted Microspheres in Active Compound Separation from Natural Product

  2024cites this paper
• Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation

  2024cites this paper
• Aaptamine: A Versatile Marine Alkaloid for Antioxidant, Antibacterial, and Anticancer Therapeutics

  2024cites this paper
• Genomic Discovery and Structure–Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors

  2024cites this paper
• My 50-Plus Years of Academic Research Collaborations with Industry. A Retrospective.

  2024cites this paper
• A Fast and Efficient Molecular Networking Approach for Reactivity of Natural Products Exploration in Plant Extracts: Application to Diterpene Esters from Euphorbia dendroides.

  2024cites this paper
• Structural and mechanistic insights into the transport of aristolochic acids and their active metabolites by human serum albumin

  2024cites this paper
• Marine seaweed endophytic fungi-derived active metabolites promote reactive oxygen species-induced cell cycle arrest and apoptosis in human breast cancer cells

  2024cites this paper
• NP3 MS Workflow: An Open-Source Software System to Empower Natural Product-Based Drug Discovery Using Untargeted Metabolomics

  2024cites this paper
• Nano-Drug Delivery Systems Based on Natural Products

  2024cites this paper
• Heterologous Production of Antimicrobial Peptides: Notes to Consider

  2024cites this paper
• Identification of Potential Antiviral Hops Compounds against Chikungunya Virus

  2023cites this paper
• Modulation of Cell Death Pathways for Cellular Protection and Anti-Tumoral Activity: The Role of Thymus spp. Extracts and Their Bioactive Molecules

  2023cites this paper
• A novel organogel of breviscapine via supramolecular self-assembly in DCM

  2023cites this paper
• Challenges in natural product-based drug discovery assisted with in silico-based methods

  2023cites this paper
• Metabolomics Applied to Cyanobacterial Toxins and Natural Products.

  2023cites this paper
• Modulatory role of terminal monomeric flavan-3-ol units in the viscoelasticity of dentin.

  2023cites this paper
• Phytotherapy and oral health

  2023cites this paper
• Unleashing Nature’s potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations

  2023cites this paper
• Alkaloids as Additional Weapons in the Fight against Breast Cancer: A review.

  2023cites this paper
• Applications of machine learning in microbial natural product drug discovery

  2023cites this paper
• Modern drug discovery using ethnobotany: A large-scale cross-cultural analysis of traditional medicine reveals common therapeutic uses

  2023cites this paper
• Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer

  2023influential citation
• Bioactive compounds for human and planetary health

  2023cites this paper
• Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents.

  2023cites this paper
• Rapid Synthesis of Benzimidazole-Fused Isoindoles by Rh(III)/Ru(II)-Catalyzed [4 + 1] Cascade C-H/N-H Annulation of 2-Arylbenzimidazoles with Alkynoates and Alkynamide.

  2023cites this paper
• Bioactive phytocompounds for oral cancer prevention and treatment: A comprehensive and critical evaluation

  2023cites this paper
• Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering

  2023cites this paper
• Chemical and cytotoxicity profiles of 11 pink pepper (Schinus spp.) samples via non-targeted hyphenated high-performance thin-layer chromatography

  2023influential citation
• Drug development, Brazilian biodiversity and political choices: Where are we heading?

  2023cites this paper
• Analysis of 2′-hydroxyflavanone (2HF) in mouse whole blood by HPLC–MS/MS for the determination of pharmacokinetic parameters

  2023cites this paper
• Embellicines C-E: Macrocyclic Alkaloids with a Cyclopenta[b]fluorene Ring System from the Fungus Sarocladium sp.

  2023cites this paper
• Metal-Infused Polyphenol-enriched Phyto-fabricated Nanoparticles: an In-depth Review of their Potent Prebiotic Properties

  2023cites this paper
• Novel Antiviral Activity of Ethyl 3-Hydroxyhexanoate Against Coxsackievirus B Infection

  2022cites this paper
• Antibacterial, Antifungal, and Cytotoxic Activity of Excoecaria agallocha Leaf Extract

  2022cites this paper
• Coriander Oil Reverses Dexamethasone-Induced Insulin Resistance in Rats

  2022cites this paper
• Recent Achievements in Total Synthesis for Integral Structural Revisions of Marine Natural Products

  2022cites this paper
• Russelioside B: a Pregnane Glycoside with Pharmacological Potential

  2022cites this paper
• Computational Screening of the Natural Product Osthole and Its Derivates for Anti-Inflammatory Activity

  2022cites this paper
• In Vitro Inhibitory and Proliferative Cellular Effects of Different Extracts of Struthanthus quercicola: A Preliminary Study

  2022cites this paper
• Natural bioactive products as promising therapeutics: A review of natural product-based drug development

  2022cites this paper
• Deep learning driven biosynthetic pathways navigation for natural products with BioNavi-NP

  2022cites this paper
• A socio-ecological critique on India’s local health traditions amidst rising incidence of global pandemics

  2022cites this paper
• Discovery of Therapeutics Targeting Oxidative Stress in Autosomal Recessive Cerebellar Ataxia: A Systematic Review

  2022cites this paper
• Microbial sophorolipids inhibit colorectal tumour cell growth in vitro and restore haematocrit in Apcmin+/− mice

  2022cites this paper
• Recent Overview of Resveratrol’s Beneficial Effects and Its Nano-Delivery Systems

  2022cites this paper
• Perception Towards COVID-19 Related Symptoms and Traditional Medicine Used for Their Management Among Patients and Their Attendants in Ethiopian Comprehensive Specialized Hospitals: A Cross-Sectional Study

  2022cites this paper
• The Potential Neuroprotective Effects of Extracts from Oat Seedlings against Alzheimer’s Disease

  2022cites this paper
• Natural products in drug discovery and development: Synthesis and medicinal perspective of leonurine

  2022cites this paper
• A Comprehensive Study to Unleash the Putative Inhibitors of Serotype2 of Dengue Virus: Insights from an In Silico Structure-Based Drug Discovery

  2022cites this paper
• Computational assessment of herbal medicine-derived compounds as potential inhibitors of SARS-CoV-2 main protease

  2022cites this paper
• Therapeutic Efficacy of Natural Product ‘C-Phycocyanin’ in Alleviating Streptozotocin-Induced Diabetes via the Inhibition of Glycation Reaction in Rats

  2022cites this paper
• Curcumin-Loaded Chitosan Nanoparticle Preparation and Its Protective Effect on Celecoxib-induced Toxicity in Rat isolated Cardiomyocytes and Mitochondria

  2022cites this paper
• Incorporating LC-MS/MS Analysis and the Dereplication of Natural Product Samples into an Upper-Division Undergraduate Laboratory Course.

  2022cites this paper
• Molecular docking analysis of PARγ with compounds from Ocimum tenuiflorum

  2021cites this paper
• Isolation of an Extract from the Soft Coral Symbiotic Microorganism Salinispora arenicola Exerting Cytoprotective and Anti-Aging Effects

  2021cites this paper
• Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature

  2021cites this paper
• Machine Learning Models for the Classification of CK2 Natural Products Inhibitors with Molecular Fingerprint Descriptors

  2021cites this paper
• Phytochemicals for the treatment of COVID-19

  2021cites this paper
• Potentiality of Nanoenzymes for Cancer Treatment and Other Diseases: Current Status and Future Challenges

  2021cites this paper